EGFR and glioblastoma: Inhibits wild type EGFR or EGFRVIII, thus preventing polymerization of microtubules which is important for vesicular trafficking and mitosis of cancer cells. Modest improvement in progression-free survival among recurrent GBM patients [216,217,218].